Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG)
about
Etiologies of epilepsy: a comprehensive reviewMagnitude of the disease burden from neurocysticercosis in a developing countryTaenia solium cysticercosisImmunology of Taenia solium taeniasis and human cysticercosisProposed diagnostic criteria for neurocysticercosisCharacterization of a novel Taenia solium oncosphere antigen.Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.Cysticercosis and epilepsy: a critical review.A novel Taenia solium protein that resembles troponin T proteins.Epidemiology of the epilepsies.Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosisTreating neurocysticercosis medically: a systematic review of randomized, controlled trials.Neurocysticercosis and epilepsy in developing countries.Workshop report: Developing an international collaborative research network in neurocysticercosis and epilepsy.Differentiating Taenia solium and Taenia saginata infections by simple hematoxylin-eosin staining and PCR-restriction enzyme analysis.TsAg5, a Taenia solium cysticercus protein with a marginal trypsin-like activity in the diagnosis of human neurocysticercosis.New insights in cysticercosis transmission.Pathogenesis of Taenia solium taeniasis and cysticercosis.A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in PeruSerologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in PeruImmunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru.Neurocysticercosis: migration of a parasite.A dot-ELISA using a partially purified cathepsin-L-like protein fraction from Taenia solium cysticerci, for the diagnosis of human neurocysticercosisActive epilepsy as indicator of neurocysticercosis in rural northwest India.Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsyIn Vitro Study of Taenia solium Postoncospheral Form.Controversies in the management of cysticercosisStandardization of a fluorescent-based quantitative adhesion assay to study attachment of Taenia solium oncosphere to epithelial cells in vitro.Neurocysticercosis among patients with first time seizure in Northern Namibia.Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosisSpinal cysticercosis: A report of two cases with review of literatureReduction in rate of epilepsy from neurocysticercosis by community interventions: the Salamá, Honduras study.Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.Neurocysticercosis in persons with epilepsy in Medellín, Colombia. The Neuroepidemiological Research Group of Antioquia.Taenia solium taeniasis and cysticercosis in three communities in north Vietnam.Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis.Prevalence of active convulsive epilepsy in an urban slum in Enugu South East Nigeria.Neurocysticercosis: An uncommon cause of drug-refractory epilepsy in North Indian population.
P2860
Q22305926-3EA23859-A72E-46C9-8ACB-E4E4CF2D1570Q24599487-3C2CC674-A71C-4DAE-BE07-DCD1A353DEEFQ24630431-50064D2F-55E7-4656-9D8F-D03D9ADECC5FQ26864296-53C06BF5-C16E-44FC-B1A7-7E2D5ED672F5Q28345027-165B68A8-0EB6-4BC6-BA8A-82E3484B5982Q30364569-9F746AAD-C26B-4938-AB96-D2C10F3B3C1DQ30975304-8CE5A765-FB66-4637-B651-3546B304A3C5Q31997730-F2731532-9434-437E-88FA-754FE26E4F94Q33393812-15583944-BB01-4034-B06A-EDC45AD84EE2Q33735546-252114C5-FC0F-4FAC-BB04-1820C4BFCD87Q33757894-2C98F529-182E-4DCB-B617-21218E5468B7Q33763509-CC606758-C793-4F33-B3B1-1BC5A9474233Q33788847-613F22A9-1D5F-48AE-81F1-E62B87B71042Q33822596-5E682D13-3FD7-48B3-9A8B-0770AF8FCD0BQ33874001-ED8F743D-3848-4672-A8E5-00D8B7217CD2Q33964888-6F89E7B0-4023-4910-9239-E477FEEE5120Q34011323-1800E1B7-6F40-46A4-92C1-779E1C815A62Q34351020-8D99F028-8CE6-4BF1-BE72-EA50F0C35BDBQ34511381-CC4D3B08-D813-4DA0-A000-FA2D91178445Q34513099-06AA3AC6-8ECE-4E3F-B9BC-A02CD2F2C354Q34513106-2D581BCE-E3AD-4E27-A228-DF1884E04FA7Q34513641-CE65E90C-59B8-4ED6-BFF6-31B119FE35B1Q34585904-0EE908B9-B169-4A0E-9E8C-61AA1963A846Q36011170-FB4E334B-5A3C-4B8D-87B0-7AA1D046882DQ36168770-5F74CBE4-BA83-4485-8FBF-BB40D76B1B0CQ36299314-B032B03C-E147-4174-978E-506710045C1AQ36567682-9D12FCB6-D7EA-4B08-81F6-6A19E6719040Q37064234-00CD0840-1157-4DBA-8A49-521CB28925B5Q37215627-DA82F5AB-10BA-4BD4-A8FD-A98944BD558CQ37235091-4ECFA7C9-C9E4-46E7-B333-2EBC096A4971Q37388322-352AE564-1CCA-431C-B9EF-D5B5F16E6D2CQ37417239-90A6B150-971F-448F-9480-52C9DEC2723EQ37833130-C6C57C5E-9D4E-4633-BAAD-9352DD2C555EQ38844933-341C1BA0-CA53-4E9B-9CB3-4C499531E8FDQ39367610-A48DDAC5-B7C0-4BB4-B973-E1268372F7AEQ39482556-A17C2CBB-14BB-4588-B50B-8417E6A44050Q39741469-01A8467C-B68C-4436-9F91-0A310D370E96Q39758151-9A6949CB-B4BB-48C9-A3ED-5CB1D9BC08EDQ40069392-D19D409D-767C-431D-BB42-537A2C42E753Q40380466-4490CCB3-E66E-405A-B3BA-63E13E32106E
P2860
Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG)
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@ast
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@en
Cysticercosis as a major cause ...... cercosis Working Group in Peru
@nl
type
label
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@ast
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@en
Cysticercosis as a major cause ...... cercosis Working Group in Peru
@nl
prefLabel
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@ast
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@en
Cysticercosis as a major cause ...... cercosis Working Group in Peru
@nl
P2093
P2860
P1433
P1476
Cysticercosis as a major cause ...... is Working Group in Peru (CWG)
@en
P2093
H H Garcia
J B Pilcher
M Alvarado
M Martinez
P2860
P304
P356
10.1016/0140-6736(93)90064-N
P407
P577
1993-01-01T00:00:00Z